LUMO — Lumos Pharma Share News
0.000.00%
Last trade - 00:00- $37.41m
- $23.89m
- $2.05m
Brief: Lumos Pharma Reports First Quarter 2022 Financial Results And Clinical Development Updates
Lumos Pharma Inc reports results for the quarter ended in March - Earnings Summary
Lumos Pharma Inc expected to post a loss of 89 cents a share - Earnings Preview
Brief: Lumos Pharma Announces A Clinical Collaboration With Massachusetts General Hospital To Evaluate Oral LUM-201 In Nonalcoholic Fatty Liver Disease In A Phase 2 Investigator-Initiated Trial
Brief: Lumos Pharma Reaches 50% Randomization Milestone in Phase 2 Trial Evaluating Oral LUM-201 in PGHD
U.S. RESEARCH ROUNDUP- Biogen, FTC Solar, Palo Alto Networks
Lumos Pharma Inc reports results for the quarter ended in December - Earnings Summary
Lumos Pharma Inc expected to post a loss of 92 cents a share - Earnings Preview
Lumos Pharma Inc reports results for the quarter ended in September - Earnings Summary
Brief: Lumos Pharma Reports Q3 2021 Financial Results
Lumos Pharma Inc expected to post a loss of $1.07 a share - Earnings Preview
Brief: Santé Health Ventures Reports 8.1% Stake In Lumos Pharma Inc As Of Aug. 20
Brief: Lumos Pharma Reports Second Quarter 2021 Financial Results And Provides Clinical And Corporate Updates
Lumos Pharma Inc reports results for the quarter ended in June - Earnings Summary
Lumos Pharma Inc expected to post a loss of $1.03 a share - Earnings Preview
Brief: Lumos Pharma Announces Industry Veteran, David Karpf, MD, Has Joined Co As Chief Medical Officer
Brief: Lumos Pharma Announces The Promotion Of COO And Chief Scientific Officer, John Mckew, PhD, To President
Brief: Lumos Pharma Appoints Mark Bach to Clinical Scientific Advisory Board
U.S. RESEARCH ROUNDUP-Chembio Diagnostics, Chevron, Texas Instruments